Design and results of a group counter-detailing DUR educational program

Pharmaceutical Research

Volumn 13, Issue 10, 1996, Pages 1445-1452

  Farris, Karen B ^a   Kirking, Duane M ^b   Shimp, Leslie A ^b   Opdycke, Ruth Ann C ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Drug Utilization Review   (United States)

Author keywords

Comparative study; Drug utilization review; Education models; Health maintenance organization; Physician's practice patterns; Prescription drugs

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG COST; DRUG USE; EDUCATION PROGRAM; HEALTH MAINTENANCE ORGANIZATION; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; TECHNIQUE;

DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 0029966167     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016007024394     Document Type: Article

References (27)

1. R. K. Schwartz, S. B. Soumerai and J. Avorn. Soc. Sci. Med. 28:577-582 (1989).
2. G. Carrin. Health Policy 7:73-94 (1987).
3. D. C. Brodie and W. E. Smith. review. Hospitals 50:143-144,146,148,150 (1976).
4. T. D. Rucker. In J. P. Morgan, D. C. Kagen (eds.), Society and Medication: Conflicting Signals for Prescribers and Patients. Lexington, MA, Lexington Books 1983, pp. 25-51.
5. S. B. Soumerai, T. J. McLaughlin and J. Avorn. Milbank Quart. 67:268-317 (1990).
6. H. L. Lipton and J. A. Bird. Med. Care 31:1069-1082 (1993).
7. D. H. Kreling and D. A. Mott. PharmacoEconomics 4:414-436 (1993).
8. J. Avorn and S. B. Soumerai. N. Engl. J. Med. 308:1457-1463 (1983).
9. W. Schaffner, W. A. Ray, C. F. Federspiel C. F. and W. O. Miller. JAMA 250:2718-2732 (1983).
10. W. A. Ray, D. B. Blazer II, W. Schaffner, C. Federspiel and R. Fink. JAMA 256:2536-2539 (2986).
11. C. O. Hershey, D. K. Porter, D. Breslau and D. I. Cohen. Med. Care 24:472-481 (1986).
12. C. O. Hershey, H. I. Goldberg and D. I. Cohen. Med. Care 26:88-93 (1988).
13. S. H. Gehlbach, W. E. Wilkinson, W. E. Hammond, N. E. Clapp, A. L. Finn, W. J. Taylor and M. Rodell. Med. Care 22:193-201 (1984).
14. R. N. Winickoff, K. L. Coltin, M. M. Morgan, R. C. Buxbaum and G. O. Burnett. Med. Care 22:527-534 (1984).
15. A. Stergachis, M. Fors, E. H. Wagner, D. D. Sims and P. Penna. Am. J. Hosp. Pharm. 44:525-529 (1987).
16. I. Y. Tamai, L. Z. Rubenstein, K. R. Josephson and J. A. Yamauchi. Drug Intell. Clin. Pharm. 21:890-895 (1987).
17. H. L. Lipton, L. A. Bero, J. A. Bird and S. J. McPhee. Med. Care 30:646-658 (1992).
18. C. J. McDonald. N. Engl. J. Med. 295:1351-1355 (1976).
19. C. J. McDonald, S. L. Hui, D. M. Smith, W. M. Tierney, S. J. Cohen, M. Weinberger and G. P. McCabe. Ann. Intern. Med. 100:130-138 (1984).
20. W. M. Tierney, S. L. Hui and C. J. McDonald. Med. Care 24:659-666 (1986).
21. C. G. Berbatis, M. J. Maher, R. J. Plumridge, J. W. Stoelwinder and S. R. Zubrick. Am. J. Hosp. Pharm. 39:98-100 (1982).
22. K. J. Fendler, A. K. Gumbhir and K. Sall. Drug Intell. Clin. Pharm. 18:627-631 (1984).
23. P. Denig, F. M. Haaijer-Ruskamp and D. H. Zijsling. DICP 24:87-93 (1990).
24. J. M. Schectman, N. K. Kanwal, W. S. Schroth and E. G. Elinsky. Med. Care 33:139-144 (1995).
25. S. B. Soumerai and J. Avorn. JAMA 263:549-556 (1990).
26. C. Kirkwood, C. Womble, C. Pigg, J. Ostrosky and W. Munroe. In Criteria for Drug Use Evaluation. Volume I. American Society of Hospital Pharmacists, Inc., Bethesda, MA, 1989, pp. 3-7.
27. D. T. Campbell and J. C. Stanley. Houghton Mifflin Co., Boston, MA, 1963.